{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n Emerging evidence from multiple studies demonstrates that BCL2L2, which encodes the anti‐apoptotic protein Bcl‑w, plays a central role in promoting cell survival by antagonizing the intrinsic mitochondrial apoptotic pathway. Bcl‑w functions by sequestering pro‑apoptotic BH3‑only proteins and by preventing the activation of effectors such as Bax and Bak, thereby limiting mitochondrial outer membrane permeabilization and caspase activation (see."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "3"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n When expressed at elevated levels, Bcl‑w is implicated in oncogenic processes by contributing to chemoresistance and enhanced survival of tumor cells. In several cancers, including lung, prostate, and gliomas, Bcl‑w is upregulated through distinct pathways—such as NF‑κB activation and PI3K/AKT signaling—or by attenuation of microRNA regulators like miR‑133B, miR‑205, and miR‑125b, thereby blunting the pro‑apoptotic response and promoting resistance to cytotoxic therapies (see."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "4", "end_ref": "6"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n Moreover, survival signals in vascular endothelial cells and hematopoietic lineages also engage anti‑apoptotic members such as Bcl‑w to support long‐term cell viability and to oppose stress‐induced apoptosis, further underscoring its pleiotropic roles in both normal physiology and disease (see."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "7"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n Of particular interest is the identification of gene fusions involving BCL2L2 and PABPN1. Although PABPN1 is known primarily as a nuclear factor involved in polyadenylation and RNA processing, its fusion with the anti‑apoptotic BCL2L2 may result in altered subcellular localization or regulatory dynamics. Such chimeric transcripts have the potential to combine the survival‐promoting properties of Bcl‑w with new functions related to RNA metabolism, thereby contributing to oncogenesis and drug resistance. This possibility is supported by findings showing that dysregulation of anti‑apoptotic molecules is often associated with the development and progression of various malignancies (see."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "9"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n Collectively, these studies underscore the multifaceted role of BCL2L2 and suggest that the fusion transcript BCL2L2‑PABPN1 could be a critical mediator in tipping the balance between cell death and survival. The resultant protein may not only enhance anti‑apoptotic signaling, but also engage alternative pathways—such as altered RNA processing—to confer a growth and survival advantage under stress. This dual functionality makes BCL2L2‑PABPN1 an attractive target for therapeutic intervention in cancers where resistance to apoptosis underlies disease progression (see."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "11"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n In summary, BCL2L2‑PABPN1 exemplifies how the convergence of anti‑apoptotic function with altered post‑transcriptional regulation may promote tumor cell survival, resistance to therapy, and overall disease aggressiveness.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Simon N Willis, Lin Chen, Grant Dewson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genes Dev (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1101/gad.1304105"}], "href": "https://doi.org/10.1101/gad.1304105"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15901672"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15901672"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Bonsu Ku, Chengyu Liang, Jae U Jung, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Evidence that inhibition of BAX activation by BCL-2 involves its tight and preferential interaction with the BH3 domain of BAX."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Res (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/cr.2010.149"}], "href": "https://doi.org/10.1038/cr.2010.149"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21060336"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21060336"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Nhan L Tran, Wendy S McDonough, Benjamin A Savitch, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14 (Fn14) signaling system regulates glioma cell survival via NFkappaB pathway activation and BCL-XL/BCL-W expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M409906200"}], "href": "https://doi.org/10.1074/jbc.M409906200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15611130"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15611130"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Susmit Suvas, Vinod Singh, Sudhir Sahdev, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Distinct role of CD80 and CD86 in the regulation of the activation of B cell and B cell lymphoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M105902200"}], "href": "https://doi.org/10.1074/jbc.M105902200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11726649"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11726649"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Mingzhong Yao, Thuy-Vi V Nguyen, Christian J Pike "}, {"type": "b", "children": [{"type": "t", "text": "Beta-amyloid-induced neuronal apoptosis involves c-Jun N-terminal kinase-dependent downregulation of Bcl-w."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neurosci (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1523/JNEUROSCI.4736-04.2005"}], "href": "https://doi.org/10.1523/JNEUROSCI.4736-04.2005"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15689551"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15689551"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Melissa Crawford, Kara Batte, Lianbo Yu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA 133B targets pro-survival molecules MCL-1 and BCL2L2 in lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2009.07.143"}], "href": "https://doi.org/10.1016/j.bbrc.2009.07.143"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19654003"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19654003"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Reut Yosef, Noam Pilpel, Ronit Tokarsky-Amiel, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ncomms11190"}], "href": "https://doi.org/10.1038/ncomms11190"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27048913"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27048913"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Wim Pierson, Bénédicte Cauwe, Antonia Policheni, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Antiapoptotic Mcl-1 is critical for the survival and niche-filling capacity of Foxp3⁺ regulatory T cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Immunol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ni.2649"}], "href": "https://doi.org/10.1038/ni.2649"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23852275"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23852275"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Y H Kim, L Girard, C P Giacomini, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.onc.1208997"}], "href": "https://doi.org/10.1038/sj.onc.1208997"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16116477"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16116477"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Biyun Wang, Hong Wang, Ziang Yang "}, {"type": "b", "children": [{"type": "t", "text": "MiR-122 inhibits cell proliferation and tumorigenesis of breast cancer by targeting IGF1R."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0047053"}], "href": "https://doi.org/10.1371/journal.pone.0047053"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23056576"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23056576"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Fabiola Cervantes-Gomez, Betty Lamothe, Jennifer A Woyach, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Pharmacological and Protein Profiling Suggests Venetoclax (ABT-199) as Optimal Partner with Ibrutinib in Chronic Lymphocytic Leukemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1078-0432.CCR-14-2809"}], "href": "https://doi.org/10.1158/1078-0432.CCR-14-2809"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25829398"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25829398"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Fardokht Abulwerdi, Chenzhong Liao, Meilan Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A novel small-molecule inhibitor of mcl-1 blocks pancreatic cancer growth in vitro and in vivo."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer Ther (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1535-7163.MCT-12-0767"}], "href": "https://doi.org/10.1158/1535-7163.MCT-12-0767"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24019208"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24019208"}]}]}]}